| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/16/2013 | US20130121974 Methods of making enhanced, autologous fat grafts |
| 05/16/2013 | CA2855660A1 Therapeutic agent for arthrosis |
| 05/16/2013 | CA2855510A1 Nampt inhibitors |
| 05/16/2013 | CA2855004A1 Nadph oxidase 4 inhibitors and use thereof |
| 05/16/2013 | CA2854911A1 Calcimimetics and methods for their use |
| 05/15/2013 | EP2592081A1 Tetrahydrocarboline derivative |
| 05/15/2013 | EP2592080A1 Crystal of fused pyridine compound salt |
| 05/15/2013 | EP2591797A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 05/15/2013 | EP2591790A1 T cell apoptosis inducer |
| 05/15/2013 | EP2591782A1 Nadph oxidase 4 inhibitors and use thereof |
| 05/15/2013 | EP2590982A1 Protein kinase inhibitors and methods of treatment |
| 05/15/2013 | EP2590956A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 05/15/2013 | EP2590659A2 Gelsolin-enrichment of blood samples through gold particles |
| 05/15/2013 | CN103108882A Polycrystalline type object of CDDO BIEA and use thereof |
| 05/15/2013 | CN103108627A Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 05/15/2013 | CN103102359A Pyrimidine compounds and application thereof |
| 05/15/2013 | CN103102352A Tyrosine kinase inhibitor indolinone derivative |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103102345A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN103102314A Benzothiazole, benzimidazole, benzoxazole derivatives and preparation method and application thereof |
| 05/15/2013 | CN103100074A Traditional Chinese medicine plaster for treating rheumatism osteopathia |
| 05/15/2013 | CN103100034A Externally used traditional Chinese medicine (TCM) preparation for treating costal chondritis |
| 05/15/2013 | CN103100033A Traditional Chinese medicine (TCM) liquor for treating chronic rheumatic arthritis |
| 05/15/2013 | CN103100010A Drug for treatment of rheumatic arthritis |
| 05/15/2013 | CN103100006A Chinese herbal medicine composition with uric acid reducing function |
| 05/15/2013 | CN103100003A Traditional Chinese medicine composition for treating acute gouty arthritis |
| 05/15/2013 | CN103099999A Traditional Chinese medicine for treating gout disease |
| 05/15/2013 | CN103099953A Chinese herbal medicine for treating rheumatoid arthritis |
| 05/15/2013 | CN103099928A Traditional Chinese medicine wine for treating lumbar vertebral degeneration |
| 05/15/2013 | CN103099927A Traditional Chinese medicine liquor for treating knee degenerative disease |
| 05/15/2013 | CN103099920A Rheumatism bone disease treatment health wine |
| 05/15/2013 | CN103099918A External traditional Chinese medicinal composition for treating scapulohumeral periarthritis |
| 05/15/2013 | CN103099912A Ointment for treating various diseases |
| 05/15/2013 | CN103099899A Traditional Chinese medicine preparation externally used for treating traumatic synovitis of knee joint |
| 05/15/2013 | CN103099889A Traditional Chinese medicine wine for treating lumbar spinal stenosis |
| 05/15/2013 | CN103099874A Externally used traditional Chinese medicine (TCM) preparation for treating local swelling at later stage of fracture |
| 05/15/2013 | CN103099869A Traditional Chinese medicine wine for treating blood obstructing lubar intervertebral disc protrusion |
| 05/15/2013 | CN103099867A Preparation method of medicine for treating hyperostosis |
| 05/15/2013 | CN103099863A Traditional Chinese medicine preparation externally used for treating meniscus injury of knee joint |
| 05/15/2013 | CN103099861A Six-vine drink for treating rheumatoid arthritis |
| 05/15/2013 | CN103099860A formula of traditional Chinese medicine for treating scapulohumeral periarthritis |
| 05/15/2013 | CN103099842A Soft capsule helpful for increasing bone density and preparation method thereof |
| 05/15/2013 | CN103099817A Osteoporosis prevention and treatment activity of antler plate extract, antler plate and Pleurotus citrinopileatus Sing compound |
| 05/15/2013 | CN103099788A Traditional Chinese medicine composite decoration from powder, preparation and decoction methods and dosage relation thereof |
| 05/15/2013 | CN103099776A Koumine sustained-release preparation and preparation method thereof |
| 05/15/2013 | CN102641507B Preparation method for methotrexate/layered double hydroxide nanocomposite |
| 05/15/2013 | CN102614115B Sodium dichlorophenolate self-emulsifying ointment |
| 05/15/2013 | CN102552714B Plaster for treating facial neuroparalysis and rheumatic arthritis |
| 05/15/2013 | CN102485215B Etodolac timed-release pellet and preparation method thereof |
| 05/15/2013 | CN102327339B Traditional Chinese medicine synovium inflammation-removing plaster for treating chronic gonarthromeningitis |
| 05/15/2013 | CN102309723B Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof |
| 05/15/2013 | CN102309475B Levocarnitine for injection and preparation method thereof |
| 05/15/2013 | CN102302753B Foot bath Chinese medicinal composition for treating heel pain of middle-aged and aged |
| 05/15/2013 | CN102284012B Gel plaster containing curcumin and bletilla hyacinthina gum and preparation method thereof |
| 05/15/2013 | CN102283828B Application of tetrahydroxybenzopyrone compound |
| 05/15/2013 | CN102283823B Application of tetrahydroxy propenone compounds |
| 05/15/2013 | CN102205070B Medicament for treating rheumatoid diseases and preparation method thereof |
| 05/15/2013 | CN102178933B Preparation for preventing and treating osteoporosis and osteoarthrosis |
| 05/15/2013 | CN102076671B Triazole derivative or salt thereof |
| 05/15/2013 | CN102014945B Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin D3 glycosides and quercetin glycosides |
| 05/15/2013 | CN101820755B Anti-inflammatory compounds and uses thereof |
| 05/15/2013 | CN101744841B Bifidobacterium for treating inflammatory disease |
| 05/15/2013 | CN101744285B Method for preparing emulsified and gelatinized functional fatty acid carrier |
| 05/15/2013 | CN101516386B Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 05/15/2013 | CN101486713B Furo[2,3-h] chromene compound and use for preventing platelet aggregation |
| 05/15/2013 | CN101171927B Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/14/2013 | US8440689 Fused heteroaromatic pyrrolidinones |
| 05/14/2013 | US8440677 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | CA2672191C (1r,6s)-2-azabicyclo[4.3.0] nonane-8,8-diphosphonic acid and its use in treating or preventing bone disorders, for example, osteoporosis or paget's disease |
| 05/14/2013 | CA2560927C Insulin resistance-improving agent |
| 05/14/2013 | CA2539193C New rarbeta receptor-activating ligand, method for the preparation ther eof and use thereof in human medicine and in cosmetics |
| 05/14/2013 | CA2497572C Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 05/14/2013 | CA2461916C Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis |
| 05/14/2013 | CA2455915C Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 05/14/2013 | CA2434303C Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 05/10/2013 | WO2013067425A1 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| 05/10/2013 | WO2013067154A1 Compositions and methods for hemostasis |
| 05/10/2013 | WO2013066640A1 Substituted pyrazole analogues as rar antagonists |
| 05/10/2013 | WO2013066623A1 Anti Aging Application and Method for Treating Aging |
| 05/10/2013 | WO2013064585A1 Treatment of musculoskeletal fibroproliferative disorders |
| 05/10/2013 | WO2013064445A1 Imidazopyridazine compounds |
| 05/10/2013 | WO2013064153A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids) |
| 05/10/2013 | WO2013044356A9 Pharmaceutical compositions comprising phosphate binder, calcium receptor-active compound and/or active vitamin d |
| 05/10/2013 | WO2012170504A3 Treatment of extracellular matrix to reduce inflammation |
| 05/10/2013 | CA2853943A1 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 05/10/2013 | CA2853655A1 Compositions and methods for hemostasis |
| 05/10/2013 | CA2852490A1 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| 05/10/2013 | CA2850516A1 Substituted pyrazole analogues as rar antagonists |
| 05/10/2013 | CA2849194A1 Imidazopyridazine compounds |
| 05/09/2013 | US20130116276 New use of neferine |
| 05/09/2013 | US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 05/09/2013 | US20130116187 Artificial cartilage and its production method |
| 05/09/2013 | US20130115269 Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseases |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/08/2013 | EP2588491A2 Novel peptide and use thereof |
| 05/08/2013 | EP2588479A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 05/08/2013 | EP2588473A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors |
| 05/08/2013 | EP2588196A2 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
| 05/08/2013 | CN202920663U Channel-regulating and collateral-activating plaster |